Literature DB >> 23660299

Highly-sensitive troponin I is increased in patients with gynecological cancers.

Elisa Danese1, Martina Montagnana2, Silvia Giudici3, Rosalia Aloe4, Massimo Franchi3, Gian Cesare Guidi2, Giuseppe Lippi4.   

Abstract

OBJECTIVES: To investigate troponin I (TnI) in patients with gynecological cancers.
METHODS: Highly-sensitive (HS) and conventional TnI were measured in 25 patients with untreated ovarian cancer, 25 with endometriosis and 25 with benign masses.
RESULTS: Both HS and conventional TnI were increase in cancer patients. Values above the cut-off were found in 44% and 16% cancer patients using HS and conventional TnI methods, respectively.
CONCLUSIONS: Cardiac involvement is frequent in patients with gynecological cancers and should be preferably assessed using HS troponin immunoassays.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Gynecological cancer; Highly-sensitive immunoassays; Troponin

Mesh:

Substances:

Year:  2013        PMID: 23660299     DOI: 10.1016/j.clinbiochem.2013.04.029

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

Review 1.  Pay attention to cardiac remodeling in cancer cachexia.

Authors:  Yawen Zheng; Han Chen; Xiaoqing Li; Yuping Sun
Journal:  Support Care Cancer       Date:  2016-04-23       Impact factor: 3.603

2.  Preoperative Midregional Pro-Adrenomedullin and High-Sensitivity Troponin T Predict Perioperative Cardiovascular Events in Noncardiac Surgery.

Authors:  Mlađjan Golubović; Radmilo Janković; Dušan Sokolović; Vladan Ćosić; Vera Maravić-Stojkovic; Tomislav Kostić; Zoran Perišić; Nebojša Lađević
Journal:  Med Princ Pract       Date:  2018-03-07       Impact factor: 1.927

3.  Clinical Characteristics and Long-Term Outcomes of MINOCA Accompanied by Active Cancer: A Retrospective Insight Into a Cardio-Oncology Center Registry.

Authors:  Konrad Stepien; Karol Nowak; Barbara Szlosarczyk; Jadwiga Nessler; Jaroslaw Zalewski
Journal:  Front Cardiovasc Med       Date:  2022-05-20

Review 4.  Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers.

Authors:  Michela Chianca; Giorgia Panichella; Iacopo Fabiani; Alberto Giannoni; Serena L'Abbate; Alberto Aimo; Annamaria Del Franco; Giuseppe Vergaro; Chrysanthos Grigoratos; Vincenzo Castiglione; Carlo Maria Cipolla; Antonella Fedele; Claudio Passino; Michele Emdin; Daniela Maria Cardinale
Journal:  Front Cardiovasc Med       Date:  2022-07-06

5.  Basic cardiovascular risk assessment in naïve patients with colon cancer.

Authors:  Liliana Radulescu; Lucretia Avram; Elena Buzdugan; Dana Crisan; Alin Grosu; Cristiana Grapa; Laurentiu Stoicescu; Valer Donca; Sorin Crisan; Valentin Militaru; Anca Buzoianu; Dan Radulescu
Journal:  Exp Ther Med       Date:  2022-03-09       Impact factor: 2.447

6.  Aberrant Expression of Cardiac Troponin-T in Lung Cancer Tissues in Association With Pathological Severity.

Authors:  Toshihiro Tsuruda; Yuichiro Sato; Masaki Tomita; Hiroyuki Tanaka; Kinta Hatakeyama; Misa Otsu; Aya Kawano; Keiko Nagatomo; Naoki Yoshikawa; Ryuji Ikeda; Yujiro Asada; Koichi Kaikita
Journal:  Front Cardiovasc Med       Date:  2022-04-11

7.  Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center.

Authors:  Jonas K Kurzhals; Tobias Graf; Katharina Boch; Ulrike Grzyska; Alex Frydrychowicz; Detlef Zillikens; Patrick Terheyden; Ewan A Langan
Journal:  Front Med (Lausanne)       Date:  2021-07-05

Review 8.  Cardiac Cachexia: Unaddressed Aspect in Cancer Patients.

Authors:  Sarama Saha; Praveen Kumar Singh; Partha Roy; Sham S Kakar
Journal:  Cells       Date:  2022-03-14       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.